FDA approves HIFU for “prostate tissue ablation”

According to a media release issued by SonaCare Medical early this morning, the company has received approval from the U.S. Food and Drug Administration (FDA) to market its Sonablate® 450 technology in the U.S.A. for prostate tissue ablation. This approval of SonaCare’s technology, based on high-intensity focused ultrasound (HIFU), is unusual in a number of […]